ReviewBioinorganic chemistry and applications2025
Inorganic Nanoparticles Containing Plant-Derived Compounds for Kidney Treatment.
Review in Bioinorganic chemistry and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Green-Synthesized Nanomaterials for Kidney Cancer: Current Progress and Future Perspectives.International journal of molecular sciences · 2026Review
- Inorganic Nanoparticles Containing Plant-Derived Compounds for Kidney Treatment.Bioinorganic chemistry and applications · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several studies have shown that many kidney diseases are associated with oxidative stress caused by factors such as changes in diet, environmental pollution, and the excessive use of medications, which contribute to cellular damage in the kidneys. This pathology, whose prevalence is increasing, presents a significant challenge for current medicine due to the multiple physiological barriers that limit the effectiveness of conventional treatments. In response to this issue, inorganic nanoparticles synthesized through green methods, using derivatives from medicinal plants as antioxidants (such as flavonoids and polyphenols, among others), have emerged as a promising therapeutic alternative. This approach not only avoids the use of toxic chemical reagents but also allows for the design of nanoparticles with specific physicochemical properties, such as size, charge, and shape, which facilitate their passage through the digestive system, evasion of the immune system, and targeted delivery to renal tissue. The objective of this study is to analyze the potential of inorganic nanoparticles as an innovative therapeutic strategy for the treatment and prevention of kidney diseases, leveraging their ability to protect the kidneys from oxidative damage caused by reactive oxygen species.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.